Morgan Stanley
DWTX

Morgan Stanley’s Dogwood Therapeutics DWTX Stock Holding History

Morgan Stanley’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.58K Buy
+2,222
New +$3.68K ﹤0.01% 7291
2026
Q1 		– Sell
-477
Closed -$1.98K – 8556
2025
Q4 		$1.98K Sell
477
-123
-21% -$724 ﹤0.01% 7243
2025
Q3 		$4.62K Sell
600
-16,850
-97% -$83.9K ﹤0.01% 7113
2025
Q2 		$83.2K Buy
17,450
+16,850
+2,808% +$81.5K ﹤0.01% 6196
2025
Q1 		$3.01K Hold
600
– – ﹤0.01% 7096
2024
Q4 		$1.49K Sell
600
-8
-1% -$26 ﹤0.01% 7236
2024
Q3 		$2.58K Buy
608
+8
+1% +$41 ﹤0.01% 7079
2024
Q2 		$3.23K Hold
600
– – ﹤0.01% 6961
2024
Q1 		$7.19K Hold
600
– – ﹤0.01% 6801
2023
Q4 		$8.63K Hold
600
– – ﹤0.01% 6704
2023
Q3 		$13.9K Hold
600
– – ﹤0.01% 6603
2023
Q2 		$20.7K Buy
+600
New +$17.1K ﹤0.01% 6556
2023
Q1 		– Hold
0
– -$3 – 7844
2022
Q4 		– Sell
-186
Closed -$1.4K – 7848
2022
Q3 		$2K Hold
186
– – ﹤0.01% 7496
2022
Q2 		$20K Hold
186
– – ﹤0.01% 6995
2022
Q1 		$21K Buy
+186
New +$27.1K ﹤0.01% 7129
2021
Q2 		– Sell
-40
Closed -$6K – 7816
2021
Q1 		$6K Sell
40
-18
-31% -$3.13K ﹤0.01% 7071
2020
Q4 		$11K Buy
+58
New +$14K ﹤0.01% 6611

Other funds holding DWTX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley's DWTX Position: Q2 2026 in Review

Morgan Stanley opened a new position in Dogwood Therapeutics (DWTX) in Q2 2026: 2,222 shares worth $3.58K. The stake represents ﹤0.01% of the portfolio and ranks #7291 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in DWTX as recently as Q4 2025.

Morgan Stanley first reported a position in DWTX in Q4 2020 and has held it in 17 quarters since. The position peaked at $83.2K in Q2 2025. 15 funds tracked by Wall St. Rank hold DWTX as of Q2 2026.

  • Morgan Stanley held 2,222 shares of Dogwood Therapeutics worth $3.58K as of Q2 2026.
  • Dogwood Therapeutics was a new Morgan Stanley position in Q2 2026.
  • Dogwood Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7291 holding.
  • Morgan Stanley first reported a position in Dogwood Therapeutics in Q4 2020 and has held it in 17 quarters since.
  • Morgan Stanley's Dogwood Therapeutics position peaked at $83.2K in Q2 2025.
  • 15 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.